Pharmaceutical Executive
July 19, 2019
Features
39
7
How one company’s cultural transformation aims to strengthen and empower its talent base.
July 16, 2019
Columns
39
7
The decision to eradicate pharma rebates and prompt direct discounts for federal beneficiaries could, if passed, upend the market-what are the critical questions for new products?
July 16, 2019
Columns
39
7
Why the time is right for P&T committees to incorporate real-world data and ‘real-world science’ into their product assessments.
July 16, 2019
Columns
39
7
Obtaining patient perspectives during open-label extension trials.
July 15, 2019
Features
39
7
Pharm Exec sits down with a pair of big pharma compliance leaders to discuss the strategic move to principles-based policies and the impact of other emerging forces influencing industry compliance practice.
July 14, 2019
Features
39
7
A look at some of the key pharma compliance challenges prevalent in the Asia-Pacific region.
July 13, 2019
Features
39
7
How pharma companies can bolster their quality management programs to meet FDA’s evolving compliance requirements.
July 11, 2019
Columns
39
7
What to make of the simmering public and political angst
July 11, 2019
Columns
39
7
New guidances open the door to interchangeables and less costly insulin.
July 09, 2019
From the Editor
39
7
Highlighting the biggest observations from this year's DIA Annual Meeting-topics likely to continue to dominate industry headlines for the foreseeable future.
July 09, 2019
Features
39
7
A review of market performance and trends in 2018 and first quarter of 2019 for the life sciences industry.
July 01, 2019
Columns
39
7
Strategies for pharma in delivering the full picture to patients.
July 01, 2019
Issue PDF
39
7
Click the title above to open the Pharmaceutical Executive July 2019 issue in an interactive PDF format.
July 01, 2019
Special Sponsored Section
39
7
In the middle of new reforms, and with its political turmoil well in the past, Egypt is striving to open the door to a brave new era of healthcare provision, where improving public healthcare has been assigned priority status.